Comparison of effect that ticagrelor and triple antiplatelet therapy affect platelet reactivity
- Title
- Comparison of effect that ticagrelor and triple antiplatelet therapy affect platelet reactivity
- Author
- 김정현
- Keywords
- Cardiac; Cardiovascular Systems; Cardiology
- Issue Date
- 2013-10
- Publisher
- ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
- Citation
- JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,2013,62(18), p B49-B49
- Abstract
- High platelet reactivity (HPR) is associated with poor prognosis in coronary artery disease. Recently PLATO subgroup analysis showed that ticagrelor is better clinical outcome than the clopidogrel, which was related with low HPR. Also many studies reported that adjunctive cilostazol to dual antiplatelet therapy (DAPT) (so called triple antiplatelet therapy; TAT) is better clinical outcome than DAPT, which was associated with a greater antiplatelet effect at 30 days. Thus, this study was designed to compare the effect of ticagrelor and TAT on platelet reactivity with PRU and ARU values.
- URI
- https://www.sciencedirect.com/science/article/pii/S0735109713042861?via%3Dihubhttp://hdl.handle.net/20.500.11754/42203
- ISSN
- 0735-1097
- DOI
- 10.1016/j.jacc.2013.08.886
- Appears in Collections:
- COLLEGE OF MEDICINE[S](의과대학) > MEDICINE(의학과) > Articles
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML